Liberty Health Sciences CEO George Scorsis, Dmitry Zaytsev & James in Miami - Midas Letter 119

3,217 views · Published 7 December 2018 · 1:29:47 · Indexed 3 October 2026

Channel: Midas Letter · 2018 · News & Politics

Watch on YouTube

Watch all interviews aired on this show as individual segments on Midas Letter Clips:
https://www.youtube.com/channel/UCkoiRxnuGEgsim
UiHOj4SVA?view_as=subscriber?sub_confirmation=1

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. Ed Milewski and Brandon Colwell provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.

0:00 - Macroeconomics and Cannabis Analysis with Brandon & Ed
-Altria (NYSE:MO) $2.4B deal with Cronos (NASDAQ:CRON)

2:55 - Midas Letter News
-Liberty Health Sciences Inc (CNSX:LHS) responds to Hindenburg report; cites factual errors; LHS had significant sales revenue increases
-Canopy Rivers (CVE:RIV) increased its stake in Canapar to 49.9%
-MedMen (CNSX:MMEN) founders purchased over 300,000 class B subordinate shares each on open market; stock rallied 20%
-Organigram (CVE:OGI) secured $10M loan for expansion

5:55 - Macroeconomics and Cannabis Analysis with Brandon & Ed
-no new developments in the BridgeMark Group story
-Aphria Inc (TSE:APHA)
-Q: opinion on delayed earnings for Organigram? A: no opinion look at chart
-Altria deal compared to Constellation deal; not as exciting, less participants in the rally
-going upstream against the market

13:15 - Visit with James in Miami
-2nd Hindenburg report hasn’t done much damage
-Hindenburg and QCM trying to intensify attack on anyone associated with Aphria/Liberty Health
-Liberty Health weathering storm
-Feels for George Scorsis, building a real company, but has predatory early stage investors; tangible assets, growing
-"buyer beware" read the listing statements etc
-investors need to know that they are the exit strategy for the founders, financiers 

30:10 - Liberty Health Sciences Inc (CNSX:LHS) CEO George Scorsis sheds some light on the content of the second Hindenburg Research report. Scorsis highlights the self-interest of short sellers as well as the many inaccurate statements in the report in defense of Liberty Health’s practices.

47:43 - Macroeconomics and Cannabis Analysis with Brandon & Ed
-S&P: lower highs
-Huawei CFO arrest

53:06 - Question of the Day
-Q: In April when weed is more accessible, will it move stocks? A: yes, plus funded capacity will come into play
-Q: is the cannabis space overhyped? A: from a technical perspective, yes; all the value that's been lost

57:33 - Analyst Dmitry Zaytsev sheds light on the two biggest cannabis stories of the week: the Hindenburg report on Aphria Inc (TSE:APHA) and Cronos Group Inc’s (TSE:CRON) partnership with Altria Inc (NYSE:MO).

1:14:49 - Video - Dry Towns: while cannabis is legal, municipalities can opt out of retail sales. Adamo Barbieri finds out more.

1:17:10 - Macroeconomics and Cannabis Analysis with Brandon & Ed
-dry towns: missing out on an economic opportunity
-S&P chart: ominous red candle, rolling over?
Q: In 5 years from now, CDN companies still on top, or from other countries? A: In 5 years from now, likely dominated by American companies

************************

Check out our website: 
https://MidasLetter.com



************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to Midas Letter Clips:
https://www.youtube.com/channel/UCkoiRxnuGEgsim
UiHOj4SVA?view_as=subscriber?sub_confirmation=1

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

#MidasLetter
#TechnicalAnalysis
#WeedStocks

More from this channel